Creative image of embryonic stem cells

CAS Données des sciences de la vie

Lorsqu'on réalise de nouvelles découvertes dans les sciences de la vie, les données connectées sont cruciales pour le succès. Examinez en profondeur les relations entre maladies, cibles et nouvelles molécules avec la source d'informations scientifiques la plus fiable et la plus utilisée au monde, CAS Collection de contenus™.

Contactez-nous

We hope you’ve been enjoying the preview of CAS life sciences content and capabilities in CAS SciFinder®, which will end on June 1, 2024. These capabilities and many more are now available through the CAS BioFinder Discovery PlatformTM, which includes CAS BioFinder™, our newest solution to serve drug discovery scientists.

CAS Life Science flag

The CAS BioFinder Discovery Platform offers seamless integration with the capabilities you’ve seen in CAS SciFinder, such as sequence searches and bioactivity tables linked to reference documents and assay details. In addition, CAS BioFinder features embedded analytical and predictive models to help you explore the predicted behavior of novel molecules. The full platform also includes CAS APIs to directly access our human-curated bioactivity and biomarker data.

With this new platform, you can dive deeper to answer key drug discovery questions with the trusted, harmonized, and connected CAS content you depend on combined with analytical and predictive models directly accessible from your search results.

  • What scaffolds and molecules are associated with my disease of interest?
  • What molecules are known or likely to interact with my target of interest?
  • What targets are known or likely to interact with my molecules of interest?
  • What biomarkers are relevant to my disease of interest?
Learn more about the new CAS BioFinder Discovery Platform

  • SAR, ADME data, toxicity values, and other bioactivity observations and pharmacological data facilitate the discovery of novel targets for therapeutic intervention.

  • Indexed nucleic acid and protein sequences provide a better understanding of how sequence changes affect biological functions.

  • Molecular biomarkers used in predictions, diagnoses, and prognoses reveal underlying causes and effects of a disease.

  • Metabolic signaling pathways and interactions further enable inferences and discoveries of connections between diseases, molecules, and pharmacological responses.

  • Antibodies, antibody-drug conjugates, antibody-fusion proteins, chimeric antigen receptors, and related engineered proteins hold diagnostic, therapeutic, or immune indications/applications.

  • Connections between disparate data types reveal reliable critical relationships.

« Le caractère exhaustif de la base de données CAS est incomparable. »

Vice-président/directeur de la recherche et du développement pour une petite entreprise de produits pharmaceutiques

TVID : 17E-012-6D1

En savoir plus sur les données des sciences de la vie